Study the Utility of Novel Drug Polymer Conjugates

  • Finnin, Barrie (Primary Chief Investigator (PCI))
  • Guymer, Robyn Heather (Chief Investigator (CI))
  • Robins-Browne, Roy (Chief Investigator (CI))
  • Allen, Penelope (Partner Investigator (PI))
  • Graichen, Florian (Partner Investigator (PI))
  • O'Shea, Mike (Partner Investigator (PI))
  • Tait, Russell (Partner Investigator (PI))

Project: Research

Project Details

Project Description

The purpose of this study is to understand the limits of performance for a novel drug polymer conjugate technology that has the potential to revolutionize release of drugs and chemicals from plastics. To date drug release from polymer systems has been limited by the amount of drug able to be incorporated into the polymer. Typically, dose loads are limited to 10% or less of the final material. Completion of studies contemplated in this proposal should show the range of drugs and polymers to which the technology can be applied and demonstrate that materials with dose loadings as high as 75% can be produced yet still retain the materials of a polymer and provide control over both the release of the drug and the erosion of the polymer.
Effective start/end date4/01/1024/05/13


  • Australian Research Council (ARC): AUD240,000.00
  • Bionics Institute: AUD50,000.00